Stocks
Blueprint Medicines Corporation (BPMC) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 365% | 10 347% | 230.1% | 5 353% | 2 590% | 2 741% | |||
| Changes by years, y/y, % | +444pp | +7 982pp | -10 117pp | +5 123pp | -2 763pp | +6.2% | |||
Blueprint Medicines Corporation. R&D/CAPEX, %
Blueprint Medicines Corporation. R&D/CAPEX, changes, pp
Blueprint Medicines Corporation (BPMC) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 4 337% | 4 309% | 1 764% | 2 054% | 7 553% | 2 741% | ||
| Changes by years, y/y, % | -4 608pp | -717pp | -1 668pp | -5 902pp | +3 215pp | |||
| Changes by quarters, q/q, % | -3 620pp | -28pp | -2 546pp | +291pp | +5 498pp | |||
